Seminars in Nephrology
Volume 29, Issue 3 , Pages 227-238 , May 2009

Epidemiology of Hyponatremia

  • Ashish Upadhyay, MD

      Affiliations

    • Renal Section, Boston Medical Center and Boston University School of Medicine, Boston, MA
    • ,
  • Bertrand L. Jaber, MD, MS

      Affiliations

    • Department of Medicine, St. Elizabeth's Medical Center and Tufts University School of Medicine, Boston, MA
    • ,
  • Nicolaos E. Madias, MD

      Affiliations

    • Department of Medicine, St. Elizabeth's Medical Center and Tufts University School of Medicine, Boston, MA
    • Corresponding Author InformationAddress reprint requests to Nicolaos E. Madias, MD, Department of Medicine, St. Elizabeth's Medical Center, 736 Cambridge St, Boston, MA 02135

References 

  1. Upadhyay A, Jaber BL, Madias NE. Incidence and prevalence of hyponatremia. Am J Med. 2006;119(Suppl 1):S30–S35
  2. Baran D, Hutchinson TA. The outcome of hyponatremia in a general hospital population. Clin Nephrol. 1984;22:72–76
  3. Kleinschmidt-DeMasters BK, Norenberg MD. Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science. 1981;211:1068–1070
  4. Owen JA, Campbell DG. A comparison of plasma electrolyte and urea values in healthy persons and in hospital patients. Clin Chim Acta. 1968;22:611–618
  5. Anderson RJ, Chung HM, Kluge R, Schrier RW. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med. 1985;102:164–168
  6. Hoorn EJ, Lindemans J, Zietse R. Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol Dial Transplant. 2006;21:70–76
  7. Hawkins RC. Age and gender as risk factors for hyponatremia and hypernatremia. Clin Chim Acta. 2003;337:169–172
  8. Tierney WM, Martin DK, Greenlee MC, Zerbe RL, McDonald CJ. The prognosis of hyponatremia at hospital admission. J Gen Intern Med. 1986;1:380–385
  9. Zilberberg MD, Exuzides A, Spalding J, Foreman A, Jones AG, Colby C, et al. Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients. Curr Med Res Opin. 2008;24:1601–1608
  10. Chung HM, Kluge R, Schrier RW, Anderson RJ. Postoperative hyponatremia (A prospective study). Arch Intern Med. 1986;146:333–336
  11. Walker MR, Fuhr PG, Koyle MA. Fatal hyponatremia in a 7-year-old girl with cloacal exstrophy after cystoscopy for a bladder stone. J Pediatr Urol. 2008;4:231–233
  12. Moritz MLAJ. Risk factors for death or neurologic impairment from hyponatremic encephalopathy in children in the new millennium [abstract]. J Am Soc Nephrol. 2006;17:38A
  13. Moritz ML, Ayus JC. Hospital-acquired hyponatremia—why are hypotonic parenteral fluids still being used?. Nat Clin Pract Nephrol. 2007;3:374–382
  14. DeVita MV, Gardenswartz MH, Konecky A, Zabetakis PM. Incidence and etiology of hyponatremia in an intensive care unit. Clin Nephrol. 1990;34:163–166
  15. Bennani SL, Abouqal R, Zeggwagh AA, Madani N, Abidi K, Zekraoui A, et al. Incidence, causes and prognostic factors of hyponatremia in intensive care. Rev Med Interne. 2003;24:224–229
  16. Hsu YJ, Chiu JS, Lu KC, Chau T, Lin SH. Biochemical and etiological characteristics of acute hyponatremia in the emergency department. J Emerg Med. 2005;29:369–374
  17. Lee CT, Guo HR, Chen JB. Hyponatremia in the emergency department. Am J Emerg Med. 2000;18:264–268
  18. Miller KK, Grinspoon SK, Ciampa J, Hier J, Herzog D, Klibanski A. Medical findings in outpatients with anorexia nervosa. Arch Intern Med. 2005;165:561–566
  19. Gankam Kengne F, Andres C, Sattar L, Melot C, Decaux G. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM. 2008;101:583–588
  20. Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med. 2006;119:71e1-8
  21. Caird FI, Andrews GR, Kennedy RD. Effect of posture on blood pressure in the elderly. Br Heart J. 1973;35:527–530
  22. Miller M, Hecker MS, Friedlander DA, Carter JM. Apparent idiopathic hyponatremia in an ambulatory geriatric population. J Am Geriatr Soc. 1996;44:404–408
  23. Terzian C, Frye EB, Piotrowski ZH. Admission hyponatremia in the elderly: factors influencing prognosis. J Gen Intern Med. 1994;9:89–91
  24. Sunderam SG, Mankikar GD. Hyponatraemia in the elderly. Age Ageing. 1983;12:77–80
  25. Miller M, Morley JE, Rubenstein LZ. Hyponatremia in a nursing home population. J Am Geriatr Soc. 1995;43:1410–1413
  26. Liamis G, Milionis H, Elisaf M. A review of drug-induced hyponatremia. Am J Kidney Dis. 2008;52:144–153
  27. Clayton JA, Rodgers S, Blakey J, Avery A, Hall IP. Thiazide diuretic prescription and electrolyte abnormalities in primary care. Br J Clin Pharmacol. 2006;61:87–95
  28. Clayton JA, Le Jeune IR, Hall IP. Severe hyponatraemia in medical in-patients: aetiology, assessment and outcome. QJM. 2006;99:505–511
  29. Sonnenblick M, Friedlander Y, Rosin AJ. Diuretic-induced severe hyponatremia (Review and analysis of 129 reported patients). Chest. 1993;103:601–606
  30. Chow KM, Szeto CC, Wong TY, Leung CB, Li PK. Risk factors for thiazide-induced hyponatraemia. QJM. 2003;96:911–917
  31. Liu BA, Mittmann N, Knowles SR, Shear NH. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports. CMAJ. 1996;155:519–527
  32. Wilkinson TJ, Begg EJ, Winter AC, Sainsbury R. Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol. 1999;47:211–217
  33. Fabian TJ, Amico JA, Kroboth PD, Mulsant BH, Corey SE, Begley AE, et al. Paroxetine-induced hyponatremia in older adults: a 12-week prospective study. Arch Intern Med. 2004;164:327–332
  34. Atalay A, Turhan N, Aki OE. A challenging case of syndrome of inappropriate secretion of antidiuretic hormone in an elderly patient secondary to quetiapine. South Med J. 2007;100:832–833
  35. Cheah CY, Ladhams B, Fegan PG. Mirtazapine associated with profound hyponatremia: two case reports. Am J Geriatr Pharmacother. 2008;6:91–95
  36. Elemery M, Dome P, Faludi G. Successful clozapine treatment of primary polydipsia associated with hyponatraemia in a schizophrenic patient (A case report). Neuropsychopharmacol Hung. 2007;9:209–213
  37. Esposito P, Rampino T, Gregorini M, Soccio G, Piotti G, Bedino G, et al. Severe symptomatic hyponatremia during sibutramine therapy: a case report. Am J Kidney Dis. 2008;52:137–139
  38. Wade JF, Dang CV, Nelson L, Wasserberger J. Emergent complications of the newer anticonvulsants. J Emerg Med. Epub 2008 Aug 30 [cited 2008 Oct 26]; 10.1016/j.jemermed.2008.03.032 http://www.elsevier.com/wps/find/journaldescription.cws_home/525473/description#description
  39. Ruiz Gines MA, Garcia Garcia S, Ruiz Gines JA, Tze Kiong E, Fernandez Rodriguez E. Symptomatic secondary hyponatraemia due to combined treatment anticonvulsant and antidepressant: risk of sudden death in epilepsy?. An Med Interna. 2007;24:335–338
  40. Vucicevic Z, Degoricija V, Alfirevic Z, Vukicevic-Badouin D. Fatal hyponatremia and other metabolic disturbances associated with psychotropic drug polypharmacy. Int J Clin Pharmacol Ther. 2007;45:289–292
  41. Hew-Butler T, Almond C, Ayus JC, Dugas J, Meeuwisse W, Noakes T, et al. Consensus statement of the 1st International Exercise-Associated Hyponatremia Consensus Development Conference, Cape Town, South Africa 2005. Clin J Sport Med. 2005;15:208–213
  42. Hew-Butler T, Jordaan E, Stuempfle KJ, Speedy DB, Siegel AJ, Noakes TD, et al. Osmotic and nonosmotic regulation of arginine vasopressin during prolonged endurance exercise. J Clin Endocrinol Metab. 2008;93:2072–2078
  43. Almond CS, Shin AY, Fortescue EB, Mannix RC, Wypij D, Binstadt BA, et al. Hyponatremia among runners in the Boston Marathon. N Engl J Med. 2005;352:1550–1556
  44. Hew TD. Women hydrate more than men during a marathon race: hyponatremia in the Houston marathon: a report on 60 cases. Clin J Sport Med. 2005;15:148–153
  45. Chorley J, Cianca J, Divine J. Risk factors for exercise-associated hyponatremia in non-elite marathon runners. Clin J Sport Med. 2007;17:471–477
  46. Speedy DB, Noakes TD, Rogers IR, Thompson JM, Campbell RG, Kuttner JA, et al. Hyponatremia in ultradistance triathletes. Med Sci Sports Exerc. 1999;31:809–815
  47. Hew TD, Chorley JN, Cianca JC, Divine JG. The incidence, risk factors, and clinical manifestations of hyponatremia in marathon runners. Clin J Sport Med. 2003;13:41–47
  48. Ayus JC, Varon J, Arieff AI. Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners. Ann Intern Med. 2000;132:711–714
  49. Clark JM, Gennari FJ. Encephalopathy due to severe hyponatremia in an ultramarathon runner. West J Med. 1993;159:188–189
  50. Gardner JW. Death by water intoxication. Mil Med. 2002;167:432–434
  51. Speedy DB, Rogers I, Safih S, Foley B. Hyponatremia and seizures in an ultradistance triathlete. J Emerg Med. 2000;18:41–44
  52. Boscoe A, Paramore C, Verbalis JG. Cost of illness of hyponatremia in the United States. Cost Eff Resour Alloc. 2006;4:10
  53. Movig KL, Leufkens HG, Lenderink AW, Egberts AC. Validity of hospital discharge International Classification of Diseases (ICD) codes for identifying patients with hyponatremia. J Clin Epidemiol. 2003;56:530–535
  54. Shea AM, Curtis LH, Szczech LA, Schulman KA. Sensitivity of International Classification of Diseases codes for hyponatremia among commercially insured outpatients in the United States. BMC Nephrol. 2008;9:5
  55. Shea AM, Hammill BG, Curtis LH, Szczech LA, Schulman KA. Medical costs of abnormal serum sodium levels. J Am Soc Nephrol. 2008;19:764–770
  56. Oren RM. Hyponatremia in congestive heart failure. Am J Cardiol. 2005;95:2B–7
  57. Gheorghiade M, Abraham WT, Albert NM, Gattis Stough W, Greenberg BH, O'Connor CM, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J. 2007;28:980–988
  58. Rossi J, Bayram M, Udelson JE, Lloyd-Jones D, Adams KF, Oconnor CM, et al. Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial. Acute Card Care. 2007;9:82–86
  59. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290:2581–2587
  60. Krumholz HM, Chen YT, Bradford WD, Cerese J. Variations in and correlates of length of stay in academic hospitals among patients with heart failure resulting from systolic dysfunction. Am J Manag Care. 1999;5:715–723
  61. Klein L, O'Connor CM, Leimberger JD, Gattis-Stough W, Pina IL, Felker GM, et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation. 2005;111:2454–2460
  62. Gheorghiade M, Rossi JS, Cotts W, Shin DD, Hellkamp AS, Pina IL, et al. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med. 2007;167:1998–2005
  63. Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation. 1986;73:257–267
  64. Konstam MA, Gheorghiade M, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007;297:1319–1331
  65. Porcel A, Diaz F, Rendon P, Macias M, Martin-Herrera L, Giron-Gonzalez JA. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med. 2002;162:323–328
  66. Angeli P, Wong F, Watson H, Gines P. Hyponatremia in cirrhosis: results of a patient population survey. Hepatology. 2006;44:1535–1542
  67. Borroni G, Maggi A, Sangiovanni A, Cazzaniga M, Salerno F. Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. Dig Liver Dis. 2000;32:605–610
  68. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130:1652–1660
  69. Londono MC, Guevara M, Rimola A, Navasa M, Taura P, Mas A, et al. Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology. 2006;130:1135–1143
  70. Dawwas MF, Lewsey JD, Neuberger JM, Gimson AE. The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study. Liver Transpl. 2007;13:1115–1124
  71. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359:1018–1026
  72. Nair V, Niederman MS, Masani N, Fishbane S. Hyponatremia in community-acquired pneumonia. Am J Nephrol. 2007;27:184–190
  73. Song JH, Oh WS, Kang CI, Chung DR, Peck KR, Ko KS, et al. Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens. Int J Antimicrob Agents. 2008;31:107–114
  74. Zilberberg MD, Exuzides A, Spalding J, Foreman A, Jones AG, Colby C, et al. Hyponatremia and hospital outcomes among patients with pneumonia: a retrospective cohort study. BMC Pulm Med. 2008;8:16
  75. Singhi S, Dhawan A. Frequency and significance of electrolyte abnormalities in pneumonia. Indian Pediatr. 1992;29:735–740
  76. Tang WW, Kaptein EM, Feinstein EI, Massry SG. Hyponatremia in hospitalized patients with the acquired immunodeficiency syndrome (AIDS) and the AIDS-related complex. Am J Med. 1993;94:169–174
  77. Cusano AJ, Thies HL, Siegal FP, Dreisbach AW, Maesaka JK. Hyponatremia in patients with acquired immune deficiency syndrome. J Acquir Immune Defic Synd. 1990;3:949–953

 Supported by grants from the National Institutes of Health (DK065102 and DK07775 to B.L.J.).

 Dr Madias has served as a consultant to and has received lecture fees from Astellas Pharma US, Inc. (manufacturer of Vaprisol–Conivaptan hydrochloride injection), and has served as a consultant to Sanofi-Aventis (manufacturer of Satavaptan).

PII: S0270-9295(09)00020-5

doi: 10.1016/j.semnephrol.2009.03.004

Seminars in Nephrology
Volume 29, Issue 3 , Pages 227-238 , May 2009

Article Tools

* Image Usage & Resolution